Abstract
In recent years, there has been significant investment from both the private and public sectors in the development of diagnostic technologies to meet the need for human immunodeficiency virus (HIV) and tuberculosis testing in low-resource settings. Future investments should ensure that the most appropriate technologies are adopted in settings where they will have a sustainable impact. Achieving these aims requires the involvement of many stakeholders, as their needs, operational constraints, and priorities are often distinct. Here, we discuss these considerations from different perspectives representing those of various stakeholders involved in the development, introduction, and implementation of diagnostic tests. We also discuss some opportunities to address these considerations.
Original language | English (US) |
---|---|
Pages (from-to) | S181-S190 |
Journal | Journal of Infectious Diseases |
Volume | 205 |
Issue number | SUPPL. 2 |
DOIs | |
State | Published - May 15 2012 |
ASJC Scopus subject areas
- Infectious Diseases
- Immunology and Allergy